Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $557B
1-Year Est. Return 24.82%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Quarter Est. Return
1 Year Est. Return
+24.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$529B
AUM Growth
+$24.4B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,330
New
Increased
Reduced
Closed

Top Buys

1 +$475M
2 +$442M
3 +$436M
4
LHX icon
L3Harris
LHX
+$355M
5
SCHW icon
Charles Schwab
SCHW
+$285M

Top Sells

1 +$1.97B
2 +$1.85B
3 +$1.71B
4
AAPL icon
Apple
AAPL
+$1.59B
5
COST icon
Costco
COST
+$728M

Sector Composition

1 Technology 28%
2 Financials 13.27%
3 Healthcare 9.87%
4 Consumer Discretionary 9.75%
5 Industrials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKYE icon
4026
Skye Bioscience
SKYE
$46.5M
-45,095
CTNM
4027
Contineum Therapeutics
CTNM
$306M
-19,899
BOLD
4028
Boundless Bio
BOLD
$28.7M
-15,360
ABOS icon
4029
Acumen Pharmaceuticals
ABOS
$124M
-90,258
ACHV icon
4030
Achieve Life Sciences
ACHV
$252M
-80,357
ACRV icon
4031
Acrivon Therapeutics
ACRV
$65.4M
-27,635
ADVM icon
4032
Adverum Biotechnologies
ADVM
$95.3M
-49,324
AGEN
4033
Agenus
AGEN
$121M
-54,727
AKYA
4034
DELISTED
Akoya BioSciences
AKYA
-45,220
ALXO icon
4035
ALX Oncology
ALXO
$70.2M
-89,199
AMTX icon
4036
Aemetis
AMTX
$133M
-88,707
ARLP icon
4037
Alliance Resource Partners
ARLP
$3.18B
-7,509
ATNM icon
4038
Actinium Pharmaceuticals
ATNM
$42.1M
-65,311
BAER icon
4039
Bridger Aerospace
BAER
$95.5M
-10,911
BBU
4040
Brookfield Business Partners
BBU
$3.06B
-19,802
BCX icon
4041
BlackRock Resources & Commodities Strategy Trust
BCX
$747M
-18,002
BEKE icon
4042
KE Holdings
BEKE
$18.8B
-741,494
BIP icon
4043
Brookfield Infrastructure Partners
BIP
$16B
-48,797
BLDP
4044
Ballard Power Systems
BLDP
$1.08B
-29,406
BLNK icon
4045
Blink Charging
BLNK
$181M
-247,250
BLUE
4046
DELISTED
bluebird bio
BLUE
-32,759
BMEA icon
4047
Biomea Fusion
BMEA
$91.9M
-73,586
CAMP icon
4048
CAMP4 Therapeutics
CAMP
$81.5M
-13,118
CBUS icon
4049
Cibus
CBUS
$69.9M
-36,508
CCCC icon
4050
C4 Therapeutics
CCCC
$219M
-141,284